Author： Zbrozek Arthur S.
Publisher： Adis International
ISSN： 1170-7690
Source： PharmacoEconomics, Vol.28, Iss.7, 2010-07, pp. : 577-584
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Temsirolimus: In Advanced Renal Cell Carcinoma
By Simpson Dene Curran Monique P.
Drugs, Vol. 68, Iss. 5, 2008-01 ,pp. :
Access to resources
Recommend
By Davide Radice Alberto Redaelli
PharmacoEconomics, Vol. 23, Iss. 1, 2005-01 ,pp. :
Phase II study of interferon-alpha and doxycycline for advanced renal cell carcinoma
By Huie Michael Oettel Kurt Ummersen Lynn Kim Kyung Zhang Yulin Staab Mary Horvath Dottie Marnocha Rebecca Douglas Jeff Drezen Amy Alberti Dona Wilding George
Investigational New Drugs, Vol. 24, Iss. 3, 2006-05 ,pp. :
Q-TWiST favours epirubicin-containing regimen in breast cancer
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 472, 2005-01 ,pp. :
Everolimus for the treatment of advanced renal cell carcinoma
By Amato Robert
Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 7, 2011-05 ,pp. :